Reckitt Benckiser Group (RBGLY) Stock Price, News & Analysis

Company Overview

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Key Stats

• Today's Range: $12.06 to $12.15
• 50-Day Range: $11.93 to $12.91
• 52-Week Range: $10.24 to $15.03
• Volume: 443,343 shs
• Average Volume: 1.77 million shs
• Market Capitalization: $41.90 billion
• P/E Ratio: N/A
• Dividend Yield: 3.21%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Reckitt Benckiser Group Stock Analysis - MarketRank™

Reckitt Benckiser Group scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Reckitt Benckiser Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.64%

Earnings Growth

Earnings for Reckitt Benckiser Group are expected to grow by 8.64% in the coming year, from $0.81 to $0.88 per share.

Price to Earnings Growth Ratio

Reckitt Benckiser Group has a PEG Ratio of 2.36. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Reckitt Benckiser Group has a P/B Ratio of 4.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of Reckitt Benckiser Group have been sold short.

Short Interest Ratio / Days to Cover

Reckitt Benckiser Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Reckitt Benckiser Group has recently decreased by 81.67%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Reckitt Benckiser Group pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Reckitt Benckiser Group does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Reckitt Benckiser Group will have a dividend payout ratio of 44.32% next year. This indicates that Reckitt Benckiser Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of Reckitt Benckiser Group have been sold short.

Short Interest Ratio / Days to Cover

Reckitt Benckiser Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Reckitt Benckiser Group has recently decreased by 81.67%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Reckitt Benckiser Group this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Reckitt Benckiser Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.12% of the stock of Reckitt Benckiser Group is held by institutions.

RBGLY Stock Analysis - Frequently Asked Questions

How have RBGLY shares performed this year?

Reckitt Benckiser Group's stock was trading at $13.74 at the beginning of 2024. Since then, RBGLY shares have decreased by 11.6% and is now trading at $12.15.
View the best growth stocks for 2024 here.

Does Reckitt Benckiser Group have any subsidiaries?

The following companies are subsidiaries of Reckitt Benckiser Group: Mead Johnson Nutrition, 0730033 BC Ltd, 103-105 Bath Road Limited, Airwick Industrie SAS, Anhui Guilong Pharmaceutical Trading Company Ltd, Beleggingsmaatschappij Lemore BV, Benckiser, and more.

How do I buy shares of Reckitt Benckiser Group?

Shares of RBGLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Ex-Dividend for 9/23 Dividend: 8/05/2024
• Dividend Payable: 9/23/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Soap & other detergents
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RBGLY
• Previous Symbol: OTCMKTS:RBGPY
• CUSIP: N/A
• CIK: 1420798
• Web: www.rb.com
• Phone: 441753217800
• Fax: 01753217899
• Employees: 40,000
• Year Founded: 1823

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 15.00
• P/E Growth: 2.36
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.97
• Current Ratio: 0.69
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $18.16 billion
• Price / Sales: 2.31
• Cash Flow: $1.26 per share
• Price / Cash Flow: 9.66
• Book Value: $2.95 per share
• Price / Book: 4.12

Miscellaneous

• Outstanding Shares: 3,448,220,000
• Free Float: N/A
• Market Cap: $41.90 billion
• Optionable: Not Optionable
• Beta: 0.45